Among DM patients, 15 (16%) needed to change their DM therapy within 1 year of pancreatic cancer diagnosis: one patient (7%) switched to diet control as DM therapy, three (20%) switched to oral treatment and 11 (73%) switched to insulin. The gene discussed is INS; the disease is pancreatic neoplasm.